Crossmark

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study

Crossref DOI link: https://doi.org/10.1038/s41391-019-0196-4

Published Online: 2019-12-11

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pacella, Claudio Maurizio http://orcid.org/0000-0002-7102-7839
Patelli, Gianluigi

Iapicca, Gennaro

Manenti, Guglielmo http://orcid.org/0000-0002-7659-5392
Perretta, Tommaso

Ryan, Colleen P.

Esposito, Renato

Mauri, Giovanni http://orcid.org/0000-0003-4726-2692
License Information

Text and Data Mining valid from 2019-12-11

Version of Record valid from 2019-12-11
More Information

Article History

Received: 30 July 2019

Revised: 12 November 2019

Accepted: 28 November 2019

First Online: 11 December 2019

Compliance with ethical standards

:

: GM, CMP and CR: consultant for Elesta SrL. All other authors have nothing to disclose.

Document is current

Any future updates will be listed below